SAM
MDGL icon

Smartleaf Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Smartleaf Asset Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79.1K Hold
150
– – ﹤0.01% 1274
2026
Q1 		$75.8K Sell
150
-37
-20% -$17.7K ﹤0.01% 1249
2025
Q4 		$109K Buy
187
+63
+51% +$32.2K ﹤0.01% 1143
2025
Q3 		$54.9K Buy
124
+73
+143% +$27.2K ﹤0.01% 1353
2025
Q2 		$15.3K Sell
51
-35
-41% -$10.4K ﹤0.01% 1665
2025
Q1 		$28.2K Buy
86
+1
+1% +$329 ﹤0.01% 1431
2024
Q4 		$26.5K Buy
85
+16
+23% +$4.5K ﹤0.01% 1491
2024
Q3 		$14.7K Buy
69
+42
+156% +$10.7K ﹤0.01% 1527
2024
Q2 		$7.71K Buy
+27
New +$6.43K ﹤0.01% 1553

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Smartleaf Asset Management's MDGL Position: Q2 2026 in Review

Smartleaf Asset Management held its Madrigal Pharmaceuticals (MDGL) position steady in Q2 2026 at 150 shares worth $79.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1274.

Smartleaf Asset Management first reported a position in MDGL in Q2 2024 and has held it in 9 quarters since. The position peaked at $109K in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Smartleaf Asset Management held 150 shares of Madrigal Pharmaceuticals worth $79.1K as of Q2 2026.
  • Smartleaf Asset Management left its Madrigal Pharmaceuticals share count unchanged in Q2 2026.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #1274 holding.
  • Smartleaf Asset Management first reported a position in Madrigal Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Smartleaf Asset Management's Madrigal Pharmaceuticals position peaked at $109K in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.